|
Sat, 05/03/2025 - 17:57 |
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG |
Regulus Therapeutics |
|
Sat, 04/05/2025 - 17:34 |
Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit |
Regulus Therapeutics |
|
Thu, 03/06/2025 - 20:34 |
Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference |
Regulus Therapeutics |
|
Tue, 02/04/2025 - 18:00 |
Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference |
Regulus Therapeutics |
|
Wed, 07/10/2024 - 23:16 |
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences |
Regulus Therapeutics |
|
Mon, 12/12/2022 - 13:25 |
Regulus Therapeutics Announces Resignation of Board Member |
Regulus Therapeutics |
|
Thu, 09/01/2022 - 19:03 |
Regulus Therapeutics to Participate in Upcoming Investor Conferences |
Regulus Therapeutics |
|
Wed, 03/23/2022 - 22:27 |
Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral Sclerosis under a Collaboration Agreement with Harvard's Brigham and Women's Hospital |
Regulus Therapeutics |
|
Wed, 09/08/2021 - 21:50 |
Regulus Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference |
Regulus Therapeutics |
|
Fri, 03/05/2021 - 16:28 |
Regulus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference |
Regulus Therapeutics |
|
Tue, 01/05/2021 - 17:08 |
Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference |
Regulus Therapeutics |
